A new broad spectrum inhibitor of esteroproteases, 4-(2-carboxyethyl) phenyl-trans-4-aminomethyl cyclohexane carboxylate hydrochloride (DV 1006).
D000933:Antifibrinolytic Agents; D007611:Aprotinin; D001777:Blood Coagulation / Q000187:drug effects; D001780:Blood Coagulation Tests; D002364:Caseins / Q000037:antagonists & inhibitors; D002918:Chymotrypsin / Q000037:antagonists & inhibitors; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology*; D004952:Esters; D005341:Fibrinolysin / Q000037:antagonists & inhibitors; D007610:Kallikreins / Q000037:antagonists & inhibitors; D007700:Kinetics; D010958:Plasminogen / Q000037:antagonists & inhibitors; D011480:Protease Inhibitors; D013300:Streptokinase / Q000037:antagonists & inhibitors; D013916:Thrombelastography; D013917:Thrombin / Q000037:antagonists & inhibitors; D014148:Tranexamic Acid / Q000031:analogs & derivatives; D014361:Trypsin Inhibitors
D000933:Antifibrinolytic Agents; D002364:Caseins; D003509:Cyclohexanecarboxylic Acids; D004952:Esters; D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; C000665:cetraxate; D014148:Tranexamic Acid; D010958:Plasminogen; D007611:Aprotinin; D013300:Streptokinase; D007610:Kallikreins; D002918:Chymotrypsin; D013917:Thrombin; D005341:Fibrinolysin